Cohance Lifesciences Limited
COHANCE
Kedudukan dalam Saham
#6358
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Harga Saham
$5.06
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$1.93B
Perubahan (1 hari)
-1.34%
Perubahan (1 tahun)
-57.33%
Negara
IN
Perdagangan Cohance Lifesciences Limited (COHANCE)
Kategori
Healthcare
EPS untuk Cohance Lifesciences Limited (COHANCE)
EPS setakat June 2025 TTM: $0.11
Menurut laporan kewangan terkini dan harga saham Cohance Lifesciences Limited, EPS semasa syarikat (TTM) adalah $0.11. Pada akhir tahun 2024, syarikat mempunyai EPS sebanyak $0.14 penurunan berbanding EPS tahun 2023 iaitu $0.20.
Sejarah EPS untuk Cohance Lifesciences Limited dari 2019 hingga 2026
EPS pada akhir setiap tahun
| Tahun | EPS | Ubah |
|---|---|---|
| 2026 (TTM) | $0.11 | -9.42% |
| 2025 | $0.12 | -13.07% |
| 2024 | $0.14 | -28.03% |
| 2023 | $0.20 | -16.30% |
| 2022 | $0.23 | 20.83% |
| 2021 | $0.19 | 17.60% |
| 2020 | $0.17 | 167.48% |
| 2019 | $0.06 | 0.00% |
EPS untuk syarikat atau pesaing yang serupa
| Syarikat | EPS | Perbezaan EPS | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 411.78% |
IN
|
